Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Sildenafil for erectile dysfunction. Drug Ther Bull 1998;36(11).
Marmor MR . Sildenafil (Viagra) and ophthalmology [editorial]. Arch OphthalmoI 1999;117:518–9.
Sildenafil. Summary of drug characteristics, UK and Ireland. Pfizer Limited, September 1998.
Vobig MA, Klotz T, Staak M, Bartz-Schmidt KU, Engelmann U, Walter P . Retinal side-effects of sildenafil. Lancet 1999;353:375.
Kloner RA, Zusman RM . Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999;84:N11–7.
Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH . Clinical safety of oral sildenafil (Viagra) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69–74.
Morbidelli L, Chang CH, Douglas JG, Granger HI, Ledda F, Ziche M . Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996;270:H411–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burton, A., Reynolds, A. & O'Neill, D. Sildenafil (Viagra) a cause of proliferative diabetic retinopathy?. Eye 14, 785 (2000). https://doi.org/10.1038/eye.2000.205
Issue date:
DOI: https://doi.org/10.1038/eye.2000.205
